Polymer Capital Management (Us) LLC Geron Corp Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Geron Corp stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 13,676 shares of GERN stock, worth $21,334. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,676
Previous 23,998
43.01%
Holding current value
$21,334
Previous $85 Million
74.4%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
295Shares Held
496MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$94.2 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$72.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$59.6 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$53.3 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$42.5 Million11.75% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $589M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...